Skip to content

Clinical trials

Thromboembolism trials in Russia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Thromboembolism Country / region: Russia Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20063
20071
20081
20092
20132
20144
20152
20161
20181
20191
20201
20211
20231
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed17
Recruiting3
Active, not recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer5
Boehringer Ingelheim4
Astellas Pharma Inc2
Daiichi Sankyo2
Boston Scientific Corporation1
Bristol-Myers Squibb1
Closed Joint-Stock Company NeoCor1
I.M. Sechenov First Moscow State Medical University1
Janssen Research & Development, LLC1
Meshalkin Research Institute of Pathology of Circulation1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Thromboembolism22
Atrial Fibrillation6
Stroke6
Thrombosis6
Venous Thromboembolism5
Hemorrhage4
Cardiovascular Diseases3
Embolism3
Pulmonary Embolism3
Venous Thrombosis3

Trials

Showing 51 to 22 of 22. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.